CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,781 JPY | +1.90% |
|
+0.70% | -10.50% |
| 05-23 | Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook | RE |
| 05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| Sales 2024 * | 1,089B 6.92B 9.43B | Sales 2025 * | 1,130B 7.18B 9.79B | Capitalization | 7,866B 49.97B 68.1B |
|---|---|---|---|---|---|
| Net income 2024 * | 345B 2.19B 2.99B | Net income 2025 * | 367B 2.33B 3.17B | EV / Sales 2024 * | 6.45 x |
| Net cash position 2024 * | 837B 5.32B 7.25B | Net cash position 2025 * | 1,020B 6.48B 8.83B | EV / Sales 2025 * | 6.06 x |
| P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
21.5
x | Employees | 7,604 |
| Yield 2024 * |
1.77% | Yield 2025 * |
1.86% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | +1.90% | ||
| 1 week | +0.70% | ||
| 1 month | -5.33% | ||
| 3 months | -20.32% | ||
| 6 months | -8.37% | ||
| Current year | -10.50% |
1 week
4 572.00
4 816.00
1 month
4 572.005 159.00
Current year
4 572.006 697.00
1 year
3 767.006 697.00
3 years
3 191.006 697.00
5 years
2 296.676 697.00
10 years
900.006 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 19 M€ | +11.22% | ||
| 1.87% | 57 M€ | +19.30% | ||
| 1.59% | 4 M€ | +19.76% | ||
| 1.53% | 64,792 M€ | +15.98% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 4,781 | +1.90% | 6,295,300 |
| 24-05-30 | 4,692 | +0.17% | 2,310,000 |
| 24-05-29 | 4,684 | -1.68% | 2,045,300 |
| 24-05-28 | 4,764 | -0.89% | 1,180,500 |
| 24-05-27 | 4,807 | +1.24% | 1,333,100 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,781
JPY
Average target price
5,975
JPY
Spread / Average Target
+24.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.50% | 49.27B | |
| +40.73% | 734B | |
| +32.83% | 591B | |
| -6.30% | 350B | |
| +15.15% | 315B | |
| +4.05% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +6.17% | 161B |
- Stock Market
- Equities
- 4519 Stock
